Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $114,217.36 -0.53%
  • Ethereum $4,126.70 -1.03%
  • BNB $1,140.65 -0.14%
  • Optimism $0.45 -2.93%
  • Arbitrum $0.33 -1.71%
  • Solana $199.67 -1.04%
  • Polygon $0.22 +2.77%
  • Cosmos $3.18 -2.36%
  • Avalanche $20.36 -2.51%
  • Bitcoin $114,217.36 -0.53%
  • Ethereum $4,126.70 -1.03%
  • BNB $1,140.65 -0.14%
  • Optimism $0.45 -2.93%
  • Arbitrum $0.33 -1.71%
  • Solana $199.67 -1.04%
  • Polygon $0.22 +2.77%
  • Cosmos $3.18 -2.36%
  • Avalanche $20.36 -2.51%
Home / ORIC Pharmaceuticals / investors

ORIC Pharmaceuticals

company

Investors

Number of Lead Investors
Number of Investors
6
21
ORIC Pharmaceuticals is funded by 21 investors. Pfizer and ArrowMark Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Yes Post-IPO Equity
ArrowMark Partners Yes Series D
Invus Yes Series D
Casdin Capital - Series D
City Hill Ventures - Series D
Correlation Ventures - Series D
EcoR1 Capital - Series D
Fidelity Management and Research Company - Series D
Foresite Capital - Series D
Hartford HealthCare Endowment - Series D
Irving Investors - Series D
Kravis Investment Partners - Series D
Memorial Sloan - Kettering Cancer Center - Series D
OrbiMed - Series D
Taiho Ventures - Series D
The Column Group - Series D
Topspin Partners - Series D
NS Investment - Series C
Topspin Fund - Series C
Trinitas Capital - Series C
Kohlberg Kravis Roberts - Series B

Contact

South San Francisco,California,United States
(650)388-5600
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions